Xcout Intel
ROSE DIAGNOSTICS INC.
ROSE Diagnostics Inc. is a healthcare and biotechnology company headquartered in Carlsbad, California. The company bridges the gap between pathology labs and cancer biopsies, notably developing the verifi LUNG test.
Subscribe to see ROSE DIAGNOSTICS INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ROSE DIAGNOSTICS INC. at a glance
ROSE DIAGNOSTICS INC. is a company headquartered in United States. Its most recent funding round raised $2.2M in July 2026. Xcout tracks 10 named people at ROSE DIAGNOSTICS INC., including Andrew Morris (President).
ROSE DIAGNOSTICS INC. leadership
- Andrew MorrisPresident
- Andrew MorrisCEO, Founder
- Adolfo VelazquezCTO, Founder
- Donna PadavanVP Clinical & Regulatory Affairs, Founder
- Eric BrouwerCSO, Founder
- Adolfo VelazquezExecutive Officer
4 more named people on record for ROSE DIAGNOSTICS INC., with roles, board committees and tenure — see the full roster →
ROSE DIAGNOSTICS INC. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.2M | — | |
| SEC Form D filing | $2.3M | — | |
| SEC Form D filing | $1M | — | |
| Seed | $1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
ROSE DIAGNOSTICS INC. competitors
A few of ROSE DIAGNOSTICS INC.'s closest competitors — see the full list of competitors and alternatives →
Decipher Biosciences, Inc. was a health care company located in San Diego, California, before being acquired by Veracyte, Inc.
Emerge Diagnostics, Inc. is a technology company specializing in diagnosis and custom software services, located in Carlsbad, California.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Definitive Diagnostics, Inc. is a biotechnology research company located in St. Louis, Missouri. The firm focuses on multi-cancer early detection platforms with high sensitivity research.
Biocept, Inc. is a molecular diagnostics company incorporated in Delaware with its headquarters and CLIA-certified laboratory located in San Diego, California. The company develops and commercializes proprietary liquid biopsy assays for biomarker testing in oncology.
Mesa Biotech, Inc. is a molecular diagnostic company headquartered in San Diego, California. The firm specializes in developing innovative diagnostic testing products and technologies for healthcare applications.
Get ROSE DIAGNOSTICS INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ROSE DIAGNOSTICS INC. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access